BIOGRAPHY
Vural Ozdemir is Associate Professor at the Centre of Genomics and Policy and the Department of Human Genetics, Faculty of Medicine, McGill University. His research interest lies at the intersection of postgenomics medicine, society and policy.
Vural is trained in medicine (MD 1990, Ankara) and clinical pharmacology (MSc 1994; PhD 1998; University of Toronto). He completed postdoctoral research in pharmacogenetics, personalized medicine, and regulatory decision‐making methods for genetic tests on polygenic health outcomes (distinct from tests for monogenic diseases), at the University of Toronto with Drs. Werner Kalow and Laszlo Endrenyi (1998‐2001). He is accredited by the American Board of Clinical Pharmacology (DABCP, 2003).
He is a principal investigator for a federal operating grant from the Canadian Institutes of Health Research (2007-2010). This work contributes to publication standards on pharmacogenomics association studies. He published on the social and policy aspects of personalized medicine, evidence-informed ethics, translational pharmacogenetics, drug-drug interactions, and is a co-inventor for 11 pharmacogenomics patents. He is President-Elect for the Pacific Rim Association for Clinical Pharmacogenetics (PRACP).
Key words:
A. Translational research in genomics and personalized medicine:
Genome-environment interactions
Personalized medicine
Pharmacokinetic-pharmacodynamic models
Pharmacovigilance
Public health genomics
Risk assessment for complex polygenic traits
Translational pharmacogenomics
Twin studies and methods for measuring genetic components
B. Social, ethical and policy aspects of genomics applications
Anticipatory governance
Genomics, society and policy
Global health diplomacy and international development in personalized medicine
Health research capacity in low- and middle-income countries
Omics science and policy
Pre-normative moral responsibilities
Post-normative vigilance
Publication guidelines in personalized medicine
Real-time monitoring
Regulation of pharmaceuticals and genomic tests
Upstream bioethics